Literature DB >> 1821382

Epidemiologic approaches for assessing health risks from complex mixtures in indoor air.

J M Samet1, W E Lambert.   

Abstract

Indoor air may be contaminated by diverse gaseous and particulate pollutants that may adversely affect health. As a basis for controlling adverse health effects of indoor air pollution, the presence of a hazard needs to be confirmed, and the quantitative relationship between exposure and response needs to be described. Toxicological, clinical, and epidemiological studies represent complementary approaches for obtaining the requisite evidence. The assessment of the effects of complex mixtures poses a difficult challenge for epidemiologists. Understanding the effects of exposure may require accurate assessment of concentrations and personal exposures to multiple agents and analytical approaches that can identify independent effects of single agents and the synergistic or antagonistic effects that may occur in mixtures. The array of epidemiological study designs for this task includes descriptive studies, cohort studies, and case-control studies, each having potential advantages and disadvantages for studying complex mixtures. This presentation considers issues related to exposure assessment and study design for addressing the effects of complex mixtures in indoor air.

Mesh:

Year:  1991        PMID: 1821382      PMCID: PMC1568397          DOI: 10.1289/ehp.919571

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  9 in total

1.  Assessment of exposure to indoor air contaminants from combustion sources: methodology and application.

Authors:  B P Leaderer; R T Zagraniski; M Berwick; J A Stolwijk
Journal:  Am J Epidemiol       Date:  1986-08       Impact factor: 4.897

Review 2.  Health effects and sources of indoor air pollution. Part II.

Authors:  J M Samet; M C Marbury; J D Spengler
Journal:  Am Rev Respir Dis       Date:  1988-01

3.  Variability of exposure measurements in environmental epidemiology.

Authors:  B Brunekreef; D Noy; P Clausing
Journal:  Am J Epidemiol       Date:  1987-05       Impact factor: 4.897

Review 4.  The interactions of tobacco smoking and other agents in cancer etiology.

Authors:  R Saracci
Journal:  Epidemiol Rev       Date:  1987       Impact factor: 6.222

Review 5.  Health effects and sources of indoor air pollution. Part I.

Authors:  J M Samet; M C Marbury; J D Spengler
Journal:  Am Rev Respir Dis       Date:  1987-12

Review 6.  Tests for interaction in epidemiologic studies: a review and a study of power.

Authors:  S Greenland
Journal:  Stat Med       Date:  1983 Apr-Jun       Impact factor: 2.373

7.  General relative risk functions for case-control studies.

Authors:  N E Breslow; B E Storer
Journal:  Am J Epidemiol       Date:  1985-07       Impact factor: 4.897

8.  Respiratory symptoms and peak flow associated with indoor and outdoor air pollutants in the southwest.

Authors:  M D Lebowitz; C J Holberg; B Boyer; C Hayes
Journal:  J Air Pollut Control Assoc       Date:  1985-11

9.  Concepts of interaction.

Authors:  K J Rothman; S Greenland; A M Walker
Journal:  Am J Epidemiol       Date:  1980-10       Impact factor: 4.897

  9 in total
  4 in total

Review 1.  Epigenetic mechanisms and the development of asthma.

Authors:  Ivana V Yang; David A Schwartz
Journal:  J Allergy Clin Immunol       Date:  2012-09-29       Impact factor: 10.793

Review 2.  The environment, epigenome, and asthma.

Authors:  Ivana V Yang; Catherine A Lozupone; David A Schwartz
Journal:  J Allergy Clin Immunol       Date:  2017-07       Impact factor: 10.793

3.  Epidemiologic study design for investigating respiratory health effects of complex air pollution mixtures.

Authors:  D W Dockery
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

4.  Methylene-tetrahydrofolate reductase contributes to allergic airway disease.

Authors:  Kenneth R Eyring; Brent S Pedersen; Kenneth N Maclean; Sally P Stabler; Ivana V Yang; David A Schwartz
Journal:  PLoS One       Date:  2018-01-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.